# Clinical Trial of Clinical Efficiency and Safety of Ergoferon in Treatment of Influenza

> **NCT01804946** · PHASE4 · COMPLETED · sponsor: **Materia Medica Holding** · enrollment: 161 (actual)

## Conditions studied

- Influenza

## Interventions

- **DRUG:** Ergoferon
- **DRUG:** Oseltamivir

## Key facts

- **NCT ID:** NCT01804946
- **Lead sponsor:** Materia Medica Holding
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-02
- **Primary completion:** 2014-04
- **Final completion:** 2014-10
- **Target enrollment:** 161 (ACTUAL)
- **Last updated:** 2015-06-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01804946

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01804946, "Clinical Trial of Clinical Efficiency and Safety of Ergoferon in Treatment of Influenza". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01804946. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*